陶勇个人主页
返回首页

陶勇

首都医科大学附属北京朝阳医院

1

参会记录

0

讲座视频

2

论文摘要

30

访问数量

0

点赞数量

专家简介 参会记录 讲座视频

北京大学医学部本科、直博;德国海德堡大学访问学者;国家自然科学基金青年科学基金项目(A)资助;

中国医师奖、首都十大健康卫士;

2025年树兰医学青年奖; 全球前2%顶尖科学家

国家重点研发计划首席科学家;

现任美国视网膜专家协会会员、美国细胞外囊泡协会会员、亚太玻璃体视网膜协会会员、中国医师协会眼科医师分会葡萄膜炎与免疫专业委员会副主任委员、中华医学会眼科分会眼免疫学组委员;

Journal of Ophthalmology》主编; Cell子刊 《Cell Biomaterials》、《The Asia-Pacific Journal of Ophthalmology》、《中华眼底病杂志》等多家杂志编委;

NEJM. Nature Biomedical Engineering, Cell Reports Medicine, Ophthalmology等杂志发表SCl论文120;

微量眼部液体检测技术为首都医科大学附属北京朝阳医院科创中心转化的第一个项目,已在全国24个省的1100余家医院得以应用,赋能3000名医生,帮助超10万疑难眼病患者寻找病因,产品获国家二类医疗器械注册证2项、获美国FDA、欧盟CE5项国际准入,服务全球患者。

Bachelor of Medicine, Peking University Health Science Center; Direct PhD; Visiting Scholar, Heidelberg University, Germany; Supported by the National Natural Science Foundation of China Young Scientist Fund (Category A);

China Physician Award; One of the Capital's Top Ten Health Guardians;

2025 Shulan Medical Youth Award; Top 2% of Global Scientists;

Chief Scientist of National Key R&D Program;

Current Memberships: American Society of Retina Specialists, American Society for Extracellular Vesicles, Asia-Pacific Vitreoretinal Society; Vice Chairman of the Uveitis and Immunology Committee, Ophthalmologist Branch, Chinese Medical Doctor Association; Member of the Ocular Immunology Group, Ophthalmology Society, Chinese Medical Association;

Editor-in-Chief, Journal of Ophthalmology; Editorial Board Member of journals including Cell Biomaterials(a Cell Press journal), The Asia-Pacific Journal of Ophthalmology, and Chinese Journal of Ocular Fundus Diseases;

Has published 120 SCI papers in journals such as The New England Journal of Medicine, Nature Biomedical Engineering, Cell Reports Medicine, and Ophthalmology.

The micro ocular fluid detection technology is the first project transformed by the Innovation Center of Beijing Chao-Yang Hospital, Capital Medical University. It has been implemented in over 1,100 hospitals across 24 provinces in China, empowering 3,000 doctors and aiding over 100,000 patients with complex eye conditions in identifying the causes of their diseases. The product has obtained 2 National Class II Medical Device Registration Certificates, as well as 5 international certifications, including approvals from the U.S. FDA and the European Union CE. It serves patients worldwide.

2026
05/28

2026视觉健康创新发展国际论坛

天津梅江会展中心

讨论点评「1」 大会发言「2」 圆桌对话「1」